Stephen Thaler’s efforts to have artificial intelligence named as inventor of patent shas been shut down again by a federal court indicating AI cannot patent.

Dr. Stephen Thaler seeks to get his artificial intelligence, DABUS, to be recognized as a patent inventor in various countries.

Thaler seeks to get its artificial intelligence (AI) neural network, DABUS, be recognized as a patent inventor in the U.S.

Read about how the Supreme Court outlined three scenarios of limitations on assignor estoppel in patent cases.

The Patent Pilot Program will come to an end in July 2021, taking with it the predictability afforded to patent litigation cases during the program.

The use of the USPTO’s new ex party appeal brief resources helps inventors and attorneys efficiently draft proper appeals.

Andrei Iancu, former USPTO Director, leaves post with highlights of his accomplishments over the past three years.

Effective December 1, 2020, amendments to the EDTX local patent rules for invalidity contentions were made to ensure a defendant an opportunity to prepare invalidity contentions as well as to reflect changes resulting from the AIA.

Learn about the provisional patent application and how it provides additional time to preserve patent rights.

Patent rights are meant to provide exclusivity. However, sometimes, it could be beneficial for parties to share research and information for a common goal.

Patents on medical inventions, including vaccines are important for the companies creating the inventions to reap the rewards of their research and innovation. However, with a global pandemic and the need for global access to a vaccine, experts express concerns regarding availability, access, and distribution of a vaccine if vaccine patents are allowed without some oversight.